Related Experiment Videos
Localized malignant mesothelioma. A clinicopathologic and flow cytometric study
T B Crotty1, J L Myers, A L Katzenstein
1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905.
The American Journal of Surgical Pathology
|April 1, 1994
Summary
Malignant mesothelioma can rarely present as a localized pleural mass. While prognosis is unpredictable, some patients achieve long-term survival after surgical removal of these rare tumors.
Area of Science:
- Oncology
- Pathology
- Surgical Oncology
Background:
- Malignant mesothelioma, a rare cancer, typically presents diffusely in the pleura.
- Localized presentations of malignant mesothelioma are uncommon and may pose diagnostic challenges.
Observation:
- Six cases of malignant mesothelioma presenting as localized pleural masses were analyzed.
- Tumor characteristics included patient demographics, asbestos exposure history, size, morphology (pedunculated vs. sessile), and histological subtypes (epithelioid vs. biphasic).
- Immunohistochemistry, electron microscopy, and flow cytometry were utilized for detailed characterization.
Findings:
- Immunohistochemical analysis showed consistent positivity for cytokeratin and epithelial membrane antigen in most cases.
- Electron microscopy revealed ultrastructural features typical of mesothelial cells.
- Flow cytometry indicated aneuploid DNA content in a majority of the analyzed tumors.
- Prognosis varied significantly, with some patients experiencing recurrence and others remaining disease-free for extended periods post-surgery.
Implications:
- Localized malignant mesothelioma represents a rare but distinct clinical entity.
- Predicting the biologic behavior and patient outcomes for these localized tumors remains challenging.
- Surgical excision can lead to long-term disease-free survival in select patients, highlighting the importance of accurate diagnosis and tailored treatment approaches.